Literature DB >> 8215292

Antibiotic susceptibility of group A streptococci: a 6-year follow-up study.

C Betriu1, A Sanchez, M Gomez, A Cruceyra, J J Picazo.   

Abstract

The susceptibility patterns of group A streptococci over the last 6 years in our hospital were determined. Since our last study, carried out in 1987, all isolates have remained very susceptible in vitro to penicillin and all of the other beta-lactam agents tested. We observed resistance to erythromycin, clindamycin, tetracycline, and ofloxacin. The prevalence of erythromycin-resistant group A streptococci did not change appreciably throughout the study period.

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8215292      PMCID： PMC188051          DOI： 10.1128/AAC.37.8.1717

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  20 in total

1.  Resistance to erythromycin in group A streptococci.

Authors:  H Seppälä; A Nissinen; H Järvinen; S Huovinen; T Henriksson; E Herva; S E Holm; M Jahkola; M L Katila; T Klaukka
Journal:  N Engl J Med       Date:  1992-01-30       Impact factor: 91.245

2.  The resurgence of group A streptococcal infections and their sequelae.

Authors:  E L Kaplan
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1991-02       Impact factor: 3.267

3.  Erythromycin-resistant Streptococcus pyogenes.

Authors:  G Phillips; D Parratt; G V Orange; I Harper; H McEwan; N Young
Journal:  J Antimicrob Chemother       Date:  1990-04       Impact factor: 5.790

4.  Erythromycin-resistant group A beta-hemolytic streptococci: prevalence at four medical centers.

Authors:  J D Arthur; J F Keiser; S L Brown; J Higbee; C E Butler
Journal:  Pediatr Infect Dis       Date:  1984 Sep-Oct

5.  Why type streptococci? The epidemiology of group A streptococci in Oxfordshire 1976-1980.

Authors:  R T Mayon-White; E M Perks
Journal:  J Hyg (Lond)       Date:  1982-06

6.  Erythromycin: a microbial and clinical perspective after 30 years of clinical use (1).

Authors:  J A Washington; W R Wilson
Journal:  Mayo Clin Proc       Date:  1985-03       Impact factor: 7.616

7.  Association of penicillin tolerance with failure to eradicate group A streptococci from patients with pharyngitis.

Authors:  K S Kim; E L Kaplan
Journal:  J Pediatr       Date:  1985-11       Impact factor: 4.406

8.  Sensitivity of group A streptococci to antibiotics. Prevalence of resistance to erythromycin in Japan.

Authors:  S Maruyama; H Yoshioka; K Fujita; M Takimoto; Y Satake
Journal:  Am J Dis Child       Date:  1979-11

9.  Susceptibility of group A beta-hemolytic Streptococcus isolates to penicillin and erythromycin.

Authors:  G R Istre; D F Welch; M I Marks; N Moyer
Journal:  Antimicrob Agents Chemother       Date:  1981-08       Impact factor: 5.191

10.  The emergence of erythromycin resistance in Streptococcus pyogenes in Fremantle, Western Australia.

Authors:  N Stingemore; G R Francis; M Toohey; D B McGechie
Journal:  Med J Aust       Date:  1989-06-05       Impact factor: 7.738
View more
  9 in total

1.  Antimicrobial resistance of 914 beta-hemolytic streptococci isolated from pharyngeal swabs in Spain: results of a 1-year (1996-1997) multicenter surveillance study. The Spanish Surveillance Group for Respiratory Pathogens.

Authors:  F Baquero; J A García-Rodríguez; J G de Lomas; L Aguilar
Journal:  Antimicrob Agents Chemother       Date:  1999-01       Impact factor: 5.191

2.  The frequency of resistance to erythromycin in group A streptococci in Ankara.

Authors:  A E Kürekçi; M Baysallar; A Karaarslan; G Emekdaş; V Köseoğlu; R Akin; O Ozcan
Journal:  Eur J Pediatr       Date:  1996-09       Impact factor: 3.183

3.  Emergence of erythromycin-resistant, clindamycin-susceptible Streptococcus pyogenes isolates in Madrid, Spain.

Authors:  I Garcia-Bermejo; J Cacho; B Orden; J I Alós; J L Gómez-Garcés
Journal:  Antimicrob Agents Chemother       Date:  1998-04       Impact factor: 5.191

Review 4.  Reconsidering sore throats. Part I: Problems with current clinical practice.

Authors:  W J McIsaac; V Goel; P M Slaughter; G W Parsons; K V Woolnough; P T Weir; J R Ennet
Journal:  Can Fam Physician       Date:  1997-03       Impact factor: 3.275

Review 5.  Optimum treatment of streptococcal pharyngitis.

Authors:  F Scaglione; G Demartini; M M Arcidiacono; J P Pintucci
Journal:  Drugs       Date:  1997-01       Impact factor: 9.546

6.  Emergence of Streptococcus pyogenes strains resistant to erythromycin in Gipuzkoa, Spain.

Authors:  E Perez-Trallero; M Urbieta; M Montes; I Ayestaran; J M Marimon
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1998-01       Impact factor: 3.267

7.  Is there an ecological relationship between rates of antibiotic resistance of species of the genus Streptococcus? The Spanish Surveillance Group for Respiratory Pathogens.

Authors:  R Gómez-Lus; J J Granizo; L Aguilar; E Bouza; A Gutierrez; J García-de-Lomas
Journal:  J Clin Microbiol       Date:  1999-10       Impact factor: 5.948

8.  Survey of emm gene sequences from pharyngeal Streptococcus pyogenes isolates collected in Spain and their relationship with erythromycin susceptibility.

Authors:  Sebastián Albertí; César García-Rey; María A Domínguez; Lorenzo Aguilar; Emilia Cercenado; Miguel Gobernado; Adela García-Perea
Journal:  J Clin Microbiol       Date:  2003-06       Impact factor: 5.948

Review 9.  [Patient consent to "antimicrobial treatment of tonsillitis"].

Authors:  C Cenjor; J A García-Rodríguez; A Ramos; J Cervera; M Tomás; F Asensi; J L Cañada; M Gobernado; T Isasiá; C López-Madroñero; M Martínez; F Pérez-Escanilla; J Picazo; J Prieto; T Sampelayo
Journal:  Acta Otorrinolaringol Esp       Date:  2003-05
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.